ANI PHARMACEUTICALS, INC Long-term Purchase Commitment, Amount
ANI PHARMACEUTICALS, INC (ANIP) reported Long-term Purchase Commitment, Amount of $100.00 thousand for the 12-month period ending 2022-12-31, per its 10-K filed 2023-03-09.
Discontinued › Notes › Commitment and Contingencies
us-gaap:LongTermPurchaseCommitmentAmount · last filed 2023-03-09
- ANI PHARMACEUTICALS, INC long-term purchase commitment, amount for fiscal 2022 was $100.00K, a 99.21% decline from fiscal 2021.
- ANI PHARMACEUTICALS, INC long-term purchase commitment, amount for fiscal 2021 was $12.60M, a 350.00% increase from fiscal 2020.
- ANI PHARMACEUTICALS, INC long-term purchase commitment, amount for fiscal 2020 was $2.80M.
| Period end | Long-term Purchase Commitment, Amount 12 month |
|---|---|
| 2022-12-31 | $100.00K 10-K · filed 2023-03-09 |
| 2021-12-31 | $12.60M 10-K · filed 2022-03-15 |
| 2020-12-31 | $2.80M 10-K · filed 2021-03-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| COMPASS Pathways plc (CMPS) | $1.812B | -4.87 | |
| Septerna, Inc. (SEPN) | United States | $1.783B | -63.01 |
| Xencor Inc (XNCR) | United States | $1.776B | -7.33 |
| Zymeworks Inc. (ZYME) | United States | $1.902B | -12.44 |
| Eton Pharmaceuticals, Inc. (ETON) | United States | $1.701B | 80.74 |
| Sarepta Therapeutics, Inc. (SRPT) | United States | $1.941B | -13.89 |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |
| Xeris Biopharma Holdings, Inc. (XERS) | United States | $1.632B | -80.10 |
| Stoke Therapeutics, Inc. (STOK) | United States | $1.630B | -9.82 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |